Author: ["Domingo F Barber","Almira Bartolomé","Carmen Hernandez","Juana M Flores","Clara Redondo","Cristina Fernandez-Arias","Montserrat Camps","Thomas Rückle","Matthias K Schwarz","Santiago Rodríguez","Carlos Martinez-A","Dimitrios Balomenos","Christian Rommel","Ana C Carrera"]
CITE.CC academic search helps you expand the influence of your papers.
Abstract
Systemic lupus erythematosus (SLE) is a chronic inflammatory disease generated by deregulation of T cell–mediated B-cell activation, which results in glomerulonephritis and renal failure. Disease is treated with immunosuppressants and cytostatic agents that have numerous side effects. Here we examine the use of inhibitors of phosphoinositide 3-kinase (PI3K) γ, a lipid kinase that regulates inflammation, in the MRL-lpr mouse model of SLE. Treatment reduced glomerulonephritis and prolonged lifespan, suggesting that P13Kγ may be a useful target in the treatment of chronic inflammation.Cite this article
Barber, D., Bartolomé, A., Hernandez, C. et al. PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat Med 11, 933–935 (2005). https://doi.org/10.1038/nm1291 